In its daily update today the Democratic Republic of the Congo (DRC) health ministry reported four more lab-confirmed cases, three in the current outbreak epicenter in Beni and one in the city of Butembo.
The Democratic Republic of the Congo (DRC) confirmed three more cases of Ebola and recorded two new deaths in the ongoing outbreak in North Kivu province.
Two of the new cases and both deaths occurred in Beni, the hots pot of the outbreak that saw violent attacks by rebel forces over the weekend. One new case was recorded in Butembo.
In an update today, the Centers for Disease Control and Prevention (CDC) announced 63 more cases of Salmonella illnesses connected to tainted beef products from JBS Tolleson, Inc. The outbreak, caused by the Newport strain of the bacterium, now stands at 120 cases in 22 states.
In an update today, the US Centers for Disease Control and Prevention (CDC) said state and federal health partners are investigating 28 more suspected acute flaccid myelitis (AFM) cases, raising the overall number of patients under investigation to 155.
The US Food and Drug Administration (FDA) on Oct 5 announced that it approved expanded use of Gardasil 9 human papillomavirus (HPV) vaccine for women and men 27 through 45 years old. The vaccine prevents certain cancers and diseases caused by the nine HPV types contained in the vaccine.
The Saudi Arabian Ministry of Health (MOH) today recorded a new case of MERS-CoV for epidemiologic week 40, which is this week.
A 49-year-old man from Najran was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). The MOH said the man was hospitalized and likely exposed to the virus in a community setting. He had not reported recent contact with camels, a known risk factor.
Fifty-seven people have fallen ill with salmonellosis, while Listeria has caused 1 death.
Massachusetts General Hospital (MGH) said today it was part of an international multisite study evaluating ZMapp, an experimental Ebola treatment. ZMapp contains three antibodies and is being used in the current outbreak in the Democratic Republic of the Congo (DRC)
The results of a phase 3 randomized, controlled clinical trial show that monotherapy with the antibiotic/beta-lacatamase inhibitor combination Vabomere (meropenem-vaborbactam) in patients with carbapenem-resistant Enterobacteriaceae (CRE) infections was associated with increased clinical cure, decreased mortality, and reduced kidney toxicity compared with the best available therapy (BAT).
A case report today from the Centers for Disease Control and Prevention (CDC) details the detection of a multidrug-resistant fungus in patients from three states.
